Leerink Partners analyst Michael Cherny has maintained their neutral stance on PINC stock, giving a Hold rating on September 3.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Michael Cherny has given his Hold rating due to a combination of factors surrounding Premier’s current market position and potential strategic moves. Although Premier has shown solid performance, it remains unique as the only publicly traded group purchasing organization (GPO), which has led to limited investor interest and uncertainty in valuation approaches. The company is nearing the completion of renegotiating its GPO contracts, which should provide more clarity on its growth trajectory.
Additionally, Premier’s valuation appears reasonable, trading at approximately 9.5-10 times the estimated EV/EBITDA for 2026, suggesting that the stock is not overvalued. The recent news of Premier being in talks for a potential go-private transaction adds another layer of complexity, as it mirrors the path of MedAssets, the only other publicly traded health GPO, which went private in 2016. While there is potential for a favorable market reaction to these developments, Cherny maintains a cautious stance, awaiting more information before adjusting his estimates or valuation framework.